Emerald Health Therapeutics, Inc. (CVE:EMH – Get Free Report)’s stock price was down 3.8% during trading on Tuesday . The stock traded as low as C$0.25 and last traded at C$0.26. Approximately 384,329 shares were traded during mid-day trading, a decline of 40% from the average daily volume of 644,760 shares. The stock had previously closed at C$0.27.
Emerald Health Therapeutics Stock Performance
The company has a debt-to-equity ratio of 35.45, a current ratio of 2.97 and a quick ratio of 2.61. The stock has a 50-day simple moving average of C$0.26 and a 200-day simple moving average of C$0.26. The stock has a market cap of C$52.28 million and a P/E ratio of -0.37.
Emerald Health Therapeutics Company Profile
Emerald Health Therapeutics, Inc, together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc and changed its name to Emerald Health Therapeutics, Inc in June 2015.
See Also
- Five stocks we like better than Emerald Health Therapeutics
- How to Capture the Benefits of Dividend Increases
- Why Taiwan Semiconductor’s 6.5% Dip Could Be a Smart Buy
- Insider Buying Explained: What Investors Need to Know
- RTX Surges to Record Highs as Defense Orders Explode
- Asset Allocation Strategies in Volatile Markets
- Smart Money Is Buying Auto Suppliers, Not Car Brands
Receive News & Ratings for Emerald Health Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emerald Health Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
